Nova Leap Health Corp.
NVLPF
$0.21
-$0.02-8.68%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.03% | 13.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.03% | 13.08% | |||
| Cost of Revenue | 4.05% | 10.87% | |||
| Gross Profit | 1.51% | 16.53% | |||
| SG&A Expenses | -1.64% | 6.80% | |||
| Depreciation & Amortization | 11.73% | 6.15% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.28% | 9.29% | |||
| Operating Income | 19.46% | 365.96% | |||
| Income Before Tax | 201.45% | -656.21% | |||
| Income Tax Expenses | 270.05% | -5,350.00% | |||
| Earnings from Continuing Operations | 188.06% | -518.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 188.06% | -518.14% | |||
| EBIT | 19.46% | 365.96% | |||
| EBITDA | 16.57% | 105.70% | |||
| EPS Basic | 189.09% | -511.11% | |||
| Normalized Basic EPS | 215.38% | -1,850.00% | |||
| EPS Diluted | 189.09% | -450.00% | |||
| Normalized Diluted EPS | 215.38% | -1,850.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.73% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||